BE858031A - Procede de fabrication d'une preparation favorisant la coagulation du sang a partir de plasma sanguin humain - Google Patents

Procede de fabrication d'une preparation favorisant la coagulation du sang a partir de plasma sanguin humain

Info

Publication number
BE858031A
BE858031A BE180368A BE180368A BE858031A BE 858031 A BE858031 A BE 858031A BE 180368 A BE180368 A BE 180368A BE 180368 A BE180368 A BE 180368A BE 858031 A BE858031 A BE 858031A
Authority
BE
Belgium
Prior art keywords
manufacturing
preparation promoting
blood plasma
blood coagulation
human blood
Prior art date
Application number
BE180368A
Other languages
English (en)
Original Assignee
Immuno A G Fur Chemisch Medizi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno A G Fur Chemisch Medizi filed Critical Immuno A G Fur Chemisch Medizi
Publication of BE858031A publication Critical patent/BE858031A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/28—Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
BE180368A 1976-08-30 1977-08-23 Procede de fabrication d'une preparation favorisant la coagulation du sang a partir de plasma sanguin humain BE858031A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT640576A AT350726B (de) 1976-08-30 1976-08-30 Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma

Publications (1)

Publication Number Publication Date
BE858031A true BE858031A (fr) 1977-12-16

Family

ID=3585985

Family Applications (1)

Application Number Title Priority Date Filing Date
BE180368A BE858031A (fr) 1976-08-30 1977-08-23 Procede de fabrication d'une preparation favorisant la coagulation du sang a partir de plasma sanguin humain

Country Status (17)

Country Link
US (1) US4160025A (fr)
AR (1) AR213861A1 (fr)
AT (1) AT350726B (fr)
BE (1) BE858031A (fr)
CA (1) CA1079191A (fr)
CH (1) CH635747A5 (fr)
DE (1) DE2734821C3 (fr)
DK (1) DK151932C (fr)
ES (1) ES461918A1 (fr)
FI (1) FI57421C (fr)
FR (1) FR2362633A1 (fr)
GB (1) GB1554051A (fr)
HU (1) HU180816B (fr)
LU (1) LU78024A1 (fr)
NL (1) NL170922C (fr)
NO (1) NO148142C (fr)
SE (1) SE443511B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
DE3165600D1 (en) * 1980-01-28 1984-09-27 Baxter Travenol Lab Prothrombin-containing therapeutic compositions and methods of producing enzymatically active blood clotting factors from prothrombin-containing blood fractions
US4287180A (en) * 1980-01-28 1981-09-01 Baxter Travenol Laboratories, Inc. Method for treating blood clotting factor inhibitors
US4286056A (en) * 1980-01-28 1981-08-25 Baxter Travenol Laboratories, Inc. Method for making therapeutic enzyme compositions
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
US4404132A (en) * 1980-05-27 1983-09-13 Cutter Laboratories, Inc. Blood coagulation promoting product
US4361510A (en) * 1980-05-27 1982-11-30 Cutter Laboratories, Inc. Blood coagulation promoting product
US4391746A (en) * 1980-05-27 1983-07-05 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
ATE15489T1 (de) * 1980-05-27 1985-09-15 Miles Lab Die blutkoagulation aktivierendes produkt und verfahren zu dessen herstellung.
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
AT368883B (de) * 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
DE3101752A1 (de) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"
US4479938A (en) * 1981-06-25 1984-10-30 Baxter Travenol Laboratories, Inc. Therapeutic composition containing factor VIIa
US4382083A (en) * 1981-06-25 1983-05-03 Baxter Travenol Laboratories, Inc. Therapeutic method for treating blood-clotting defects with factor VIIa
JPS5866054A (ja) * 1981-10-14 1983-04-20 Sekisui Chem Co Ltd 血液検査用容器
JPS58105064A (ja) * 1981-12-17 1983-06-22 Sekisui Chem Co Ltd 血液凝固促進剤
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
US5118614A (en) * 1988-01-18 1992-06-02 Tessek Sdruzeni Praha Concentrates of coagulation factors ii, vii, ix and x, method of their preparation and use
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
AT398079B (de) * 1991-11-04 1994-09-26 Immuno Ag Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
EP0674531A1 (fr) * 1992-12-16 1995-10-04 IMMUNO Aktiengesellschaft Procede de preparation de compositions biologiques exemptes de virus
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
US5677162A (en) * 1995-05-01 1997-10-14 New York Blood Center, Inc. Method for activating prothrombin to thrombin
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
SI0796623T1 (en) * 1996-03-20 2005-10-31 Baxter Aktiengesellschaft Pharmaceutical preparation for the treatment of blood coagulation disorders
AT405485B (de) 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
EP1528930B1 (fr) * 2002-07-23 2009-04-15 Bio & Bio Licensing SA Preparations pharmaceutiques de substances actives a capacite de production de thrombine et contenant de la thrombine et medicaments
EP1523327A1 (fr) * 2002-07-23 2005-04-20 Bio-Products & Bio-Engineering Aktiengesellschaft Preparations de principes actifs pharmaceutiques et medicaments generant ou contenant de la thrombine
EP2305289A1 (fr) 2009-09-16 2011-04-06 Bio-Products & Bio-Engineering Aktiengesellschaft Produits médicinaux pour le traitement de troubles de la coagulation sanguine
IS2809B (is) * 2011-03-08 2012-10-15 Haskoli Islands Blóðstorkumæling
RU2648517C1 (ru) * 2017-06-23 2018-03-26 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения Российской Федерации (ФГБУ ГНЦ Минздрава России) Способ получения лиофилизированного препарата активированного протромбинового комплекса, обладающего фактор viii-шунтирующей активностью
JP2022041059A (ja) * 2020-08-31 2022-03-11 シスメックス株式会社 検量線の表示方法および分析装置
JP2025522101A (ja) 2022-07-12 2025-07-10 ビオメディツィニーシェ フォルシュング ウント ビオ－プロドゥクト ゲーエムベーハー 止血を促進するための薬剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2262520C3 (de) * 1972-12-20 1987-02-12 Miles Laboratories, Inc., Elkhart, Ind. Verfahren zur Herstellung eines lyophilisierten, lagerfähigen Konzentrats aus menschlichem Plasma
DE2459291C3 (de) * 1974-12-14 1981-06-04 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines antihämophiles Globulin A enthaltenden Konzentrats neben einem Prothrombin- Komplex und einer Lösung von lagerstabilen Serumproteinen
US3998946A (en) * 1975-04-23 1976-12-21 The Regents Of The University Of Minnesota Fibrinogen-free plasminogen-plasmin-free plasma and method of preparing and using same
DD121793A1 (fr) * 1975-07-17 1976-08-20
US4027013A (en) * 1976-01-22 1977-05-31 William L. Wilson Clottable fibrinogen free factor VIII and albumin product and process

Also Published As

Publication number Publication date
US4160025A (en) 1979-07-03
NO772978L (no) 1978-03-01
LU78024A1 (fr) 1978-01-11
CA1079191A (fr) 1980-06-10
ES461918A1 (es) 1978-12-16
DK151932B (da) 1988-01-18
ATA640576A (de) 1978-11-15
CH635747A5 (de) 1983-04-29
FR2362633A1 (fr) 1978-03-24
AT350726B (de) 1979-06-11
DK384577A (da) 1978-03-01
NL170922B (nl) 1982-08-16
FI57421B (fi) 1980-04-30
DE2734821B2 (de) 1980-11-06
NO148142C (no) 1983-08-17
AR213861A1 (es) 1979-03-30
NL7708872A (nl) 1978-03-02
FR2362633B1 (fr) 1981-06-12
DE2734821A1 (de) 1978-03-02
GB1554051A (en) 1979-10-17
NL170922C (nl) 1983-01-17
NO148142B (no) 1983-05-09
DE2734821C3 (de) 1985-03-14
SE7707992L (sv) 1978-03-01
HU180816B (en) 1983-04-29
FI772408A7 (fi) 1978-03-01
FI57421C (fi) 1980-08-11
DK151932C (da) 1988-06-20
SE443511B (sv) 1986-03-03

Similar Documents

Publication Publication Date Title
OA06368A (fr) Procédé de production d'une préparation de facteur antihémophilique à partir de plasma de sang humain.
FR2434629B1 (fr) Procede de fabrication d'un instrument medical, notamment d'un tube d'un catheter
DK384577A (da) Fremgangsmaade til fremstilling af et blodstoerkningsfremmende praeparat af menneskelig blodplasma
NO157245C (no) Fremgangsmaate ved fremstilling av et blodkoagulasjonsfremmende preparat paa basis av humanproteiner.
IT1115552B (it) Procedimento per l'eliminazione selettiva delle lipoproteine dal plasma o siero sanguigno
FR2509180B1 (fr) Oxygenateur de sang
BR8108606A (pt) Mascara cirurgica descartavel e metodo de produzir a mesma
NO171398C (no) Patron for innfoering av et medisinsk middel
BE865916A (fr) Procede de fabrication d'une electrode bipolaire
FR2591433B1 (fr) Procede de fabrication de fromages a pate molle
MX5405E (es) Metodo para separar el factor ix de coagulacion de la sangre a partir del plasma
BE895961A (fr) Procede de preparation d'un clone bacterien produisant de 1'alpha 1-antitrypsine humaine
FR2621489B1 (fr) Appareil oxygenateur de sang
BE881131A (fr) Oxygenateur du sang a bulles
BE891629A (fr) Promoteur de coagulation du sang et procede l'utilisant
EP0315627A4 (fr) Procede de traitement du sang.
FR2607808B1 (fr) Procede de preparation de trifluoromethylbenzonitrile a partir de trifluoromethylbenzaldehyde
DE3674321D1 (de) Behandlung geschmeidiger gewebe.
FR2350335A1 (fr) Procede de preparation du sulfate de l'octapeptidamide de la cholecystokinine-pancreozymine
FR2600078B1 (fr) Procede de preparation de facteur xiii a partir du placenta
FR2621582B1 (fr) Procede de preparation de 1,1,1-trifluoro-2,2-dichloroethane a partir du trifluorotrichloroethane
NO171346C (no) Patron for innfoering av et medisinsk middel
JPS54151950A (en) Novel alicyclic ketoamine*its manufacture and hypotensive*blood circulation improving and antiinflammatory medicine
DE3668338D1 (de) Kontinuierliche behandlung von spannungslosem gewebe.
RO64675A2 (fr) Procede et installation pour l'obtention de la gammaglobuline du sang placentaire humain

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: IMMUNO A.G. FUR CHEMISCH-MEDIZINISCHE PRODUKTE

Effective date: 19970823